# Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP

> **NCT03692143** · — · ACTIVE_NOT_RECRUITING · sponsor: **Nanfang Hospital, Southern Medical University** · enrollment: 90 (estimated)

## Conditions studied

- Osteoporosis, Postmenopausal
- Vertebral Fracture
- Quality of Life

## Interventions

- **DRUG:** Teriparatide
- **PROCEDURE:** PVP
- **DRUG:** Alendronate

## Key facts

- **NCT ID:** NCT03692143
- **Lead sponsor:** Nanfang Hospital, Southern Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-01-01
- **Primary completion:** 2025-03-01
- **Final completion:** 2030-12-01
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2018-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03692143

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03692143, "Comparation of Treatment Strategies for OVF: Teriparatide Injection and PVP". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03692143. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*